Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors
about
Restless Legs Syndrome: Current Concepts about Disease PathophysiologyHypoxia-activated metabolic pathway stimulates phosphorylation of p300 and CBP in oxygen-sensitive cellsAnalytic Models of Oxygen and Nutrient Diffusion, Metabolism Dynamics, and Architecture Optimization in Three-Dimensional Tissue Constructs with Applications and Insights in Cerebral OrganoidsHIF2 alpha reduces growth rate but promotes angiogenesis in a mouse model of neuroblastomaParagangliomas/Pheochromocytomas: clinically oriented genetic testingUrocortin 2 lowers blood pressure and reduces plasma catecholamine levels in mice with hyperadrenergic activity.Hypoxia promotes dopaminergic differentiation of mesenchymal stem cells and shows benefits for transplantation in a rat model of Parkinson's disease.Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment.Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency.Hypoxia. 3. Hypoxia and neurotransmitter synthesis.Does amifostine reduce metabolic rate? Effect of the drug on gas exchange and acute ventilatory hypoxic response in humans.HIF1α is necessary for exercise-induced neuroprotection while HIF2α is needed for dopaminergic neuron survival in the substantia nigra pars compacta.Hypoxic preconditioning protects against ischemic brain injury.Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.Tryptophan hydroxylase: a target for neuroendocrine disruption.Hypoxia inducible factor-1 as a target for neurodegenerative diseases.Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.Complex molecular regulation of tyrosine hydroxylase.Expression of Tyrosine Hydroxylase is Negatively Regulated Via Prion Protein.Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.Molecular Mechanism Underlying the Action of Substituted Pro-Gly Dipeptide Noopept.Von hippel-lindau disease: a new approach to an old problem.Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia.Tyrosine hydroxylase expression and activity in the rat brain: differential regulation after long-term intermittent or sustained hypoxia.Developmental changes in HIF transcription factor in carotid body: relevance for O2 sensing by chemoreceptors.Loss of SDHB Elevates Catecholamine Synthesis and Secretion Depending on ROS Production and HIF Stabilization.Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation.Hypoxia-inducible factor pathway activation in restless legs syndrome patients.Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function.HIF-2α is essential for carotid body development and function.
P2860
Q26740533-3E8AF824-440D-4C42-87A9-2FF91855F829Q28584093-3EF4200C-0E6F-423F-BC5A-4688C106CE71Q28973607-E0A0DE1F-7B10-4C54-82FB-9F5153231D96Q33291872-3C164FEB-CD46-4809-A98B-BD1D020C6DB9Q33679204-997BF193-147C-4D6C-B07D-6B8C439454E1Q34157553-31636705-9913-4306-B32A-4505831454D8Q34559310-97A90E2A-2A44-4803-83EC-081DA6716D6EQ34568841-41E46325-421B-43DE-814F-2131C81FC506Q34572866-1A8E1491-F087-414C-87D4-0CEB891E9BB3Q34782170-1368D27A-8C42-4D5C-81FA-78BC1423AB44Q35818358-8D84C3CA-EEB4-44E2-960A-CC724881FFC1Q35915111-2BAEA15B-9D4B-4F4E-A711-8BD916C900C8Q36045209-80037D13-BB26-4631-8D56-054C62EC8F31Q37202015-0FEBC695-7BA2-486D-89A0-0AF30F95C63CQ37905812-8364B9E1-AC9F-4FE0-A052-430E7FD63493Q37921345-5B881025-3D37-4CFA-B1ED-2EE48A295E99Q38051726-5D7B049E-ED19-48A5-97CB-95EE55C97291Q38215359-68C1002B-C36F-40E6-BDCC-9158CC93E009Q38786544-12630917-2394-4AA4-BF74-9348617FE116Q39164389-3134160E-C4D8-41B7-AE76-BAE372045ABAQ39834826-1662EDFD-6405-4E45-8B0D-DC5C2DC2FE32Q43114697-719620CD-D6EF-4B55-9AD7-ABE1123BA54DQ45166534-B9048800-CE10-42FF-B1CC-CC2524D056C9Q46427741-F6982A34-D272-40F4-A644-1B22F713A7FAQ46477588-9B763E2B-53D3-465B-9024-DA95589AA028Q46631747-FB3D571D-10FB-410E-AC74-28A42C1B938EQ48119740-DE976E54-E5EB-4A7D-96D8-26EA58A71740Q48853582-F36A62E3-7795-4363-AE06-4CDD9F14167EQ54979172-FBFAECE9-6E31-4543-B3D1-882D329D202FQ55338865-BFC97C01-693D-4A02-A3D6-D103D138928F
P2860
Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors
description
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
scientific journal article
@en
vedecký článok (publikovaný 2003/04/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/04/01)
@nl
наукова стаття, опублікована у квітні 2003
@uk
مقالة علمية (نشرت في أبريل 2003)
@ar
name
Regulation of tyrosine hydroxy ...... nducible transcription factors
@ast
Regulation of tyrosine hydroxy ...... nducible transcription factors
@en
Regulation of tyrosine hydroxy ...... nducible transcription factors
@nl
type
label
Regulation of tyrosine hydroxy ...... nducible transcription factors
@ast
Regulation of tyrosine hydroxy ...... nducible transcription factors
@en
Regulation of tyrosine hydroxy ...... nducible transcription factors
@nl
prefLabel
Regulation of tyrosine hydroxy ...... nducible transcription factors
@ast
Regulation of tyrosine hydroxy ...... nducible transcription factors
@en
Regulation of tyrosine hydroxy ...... nducible transcription factors
@nl
P2093
P3181
P1476
Regulation of tyrosine hydroxy ...... nducible transcription factors
@en
P2093
Amy L. Bauer
Justin B. Striet
Maria F. Czyzyk-Krzeska
Monika L. Ignacak
Phillip O. Schnell
Waltke R. Paulding
P304
P3181
P356
10.1046/J.1471-4159.2003.01696.X
P407
P577
2003-04-01T00:00:00Z